Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD

Summary

This study primarily evaluates the efficacy and safety of oral SSS17 capsules in treating anemia in patients with non-dialysis chronic kidney disease, as well as the pharmacokinetic and pharmacodynamic (PK/PD) characteristics of different doses of SSS17 capsules for anemia treatment in this patient population.

Timeline

Start

2023-03-01

Primary completion

2024-12-12

Completion

2025-04-08

Drugs

Indications